Originally published February 25, 2022 and updated July 7, 2022 to include companion Table 1 This is Issue 8 in CLI’s On Science series. To view this report as a PDF, see: Handbook of Nascent Human Beings: A Visual Aid for Understanding the Science and Experimentation. To view the companion paper, please see: “Handbook […]
The third and most recent round of grants awarded earlier this year for stem cell research by the state of Minnesota tracks a pattern established with the two earlier rounds of grants: a noticeable lack of support for human embryonic stem cell research.
In a recent op-ed, Dr. David Prentice and Congressman Jim Banks argue that it’s time for a change in leadership at the National Institutes of Health: Dr. Francis Collins has not shown any pro-life leadership at the National Institutes of Health (NIH). In fact, in an interview, Dr. Collins‘ response to a congressional letter outlining pro-life members’ […]
In 2013, the California Institute for Regenerative Medicine (CIRM) – the nation’s largest funder of stem cell research outside of the federal government – authorized a new program, the Alpha Stem Cell Clinics Network.
The Network’s goal, according to CIRM, “is to accelerate the development and delivery of stem cell treatments to patients.” To achieve this, CIRM approved $70 million “to create a new statewide network of sites that will act as a hub for stem cell clinical trials.” CIRM envisioned a network of “up to five clinic sites at established academic institutions.” To date, three Alpha Stem Cell Clinics have been created, housed at City of Hope, University of California San Diego, and UCLA/UC Irvine.
Paul Wagle, M.A., is the Director of Life Science Development for the lead economic agency in the state of Kansas. Mr. Wagle was diagnosed with leukemia at the age of 10, and after a four-year battle including an adult stem cell transplant, he has been cured for over 10 years.